Reduction in ventricular fibrillation using calcium-enriched Renografin 76

Area of Science:

• Cardiovascular medicine
• Radiology
• Pharmacology

Background:

• Renografin 76 is a widely used iodinated contrast medium.
• Calcium-binding properties of Renografin 76 have been observed both in laboratory and living organisms.
• Potential adverse effects related to contrast media composition warrant investigation.

Purpose of the Study:

• To compare the effects of standard Renografin 76 and a modified version with added calcium chloride dihydrate.
• To investigate the role of calcium binding in the incidence of ventricular fibrillation.
• To assess the safety profile of Renografin 76 in cardiovascular contrast procedures.

Main Methods:

• Selective injection of two contrast media solutions into the right coronary artery of dogs.
• Comparison between commercially available Renografin 76 and Renografin 76 with added calcium chloride dihydrate (24 mMols/liter).
• Monitoring and statistical analysis of the occurrence of ventricular fibrillation.

Main Results:

• Ventricular fibrillation occurred significantly more frequently with the stock Renografin 76 compared to the modified solution.
• The addition of calcium chloride dihydrate to Renografin 76 appeared to mitigate the proarrhythmic effect.
• These findings suggest a link between the calcium-binding capacity of Renografin 76 and cardiac electrical instability.

Conclusions:

• The calcium-binding properties of Renografin 76 may contribute to adverse cardiac events like ventricular fibrillation.
• Modifying Renografin 76 by adding calcium chloride dihydrate may reduce the risk of such events.
• Further research into the mechanisms of calcium binding and its clinical implications for contrast media is recommended.